Cure of unresectable, locally advanced pancreatic cancer after multidisciplinary therapy
The treatment of unresectable, locally advanced pancreatic cancer (ULAPC) is highly challenging as it is considered to be an incurable disease. Our previous studies demonstrated that the combination of gemcitabine, oxaliplatin and 46-h infusion of fluorouracil (5-FU) and leucovorin, the GOFL regimen...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2018-03-01
|
Series: | Journal of Cancer Research and Practice |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2311300617300745 |